Intraocular Lens Market by Type, Material and End User - Global Opportunity Analysis and Industry Forecast, 2014-2022

  • ID: 4227006
  • Report
  • Region: Global
  • 131 pages
  • Allied Analytics LLP
1 of 5

FEATURED COMPANIES

  • Carl Zeiss Meditec AG
  • EyeKon Medical, Inc.
  • HOYA GROUP
  • HumanOptics AG
  • Johnson & Johnson
  • Lenstec, Inc.
  • MORE

Intraocular Lens Market by Type [Monofocal Intraocular Lens and Premium Intraocular Lens (Toric Intraocular Lens, Multifocal Intraocular Lens, and Accommodating Intraocular Lens)], Material [Polymethylmethacrylate (PMMA), Silicone and Hydrophobic Acrylic], and End User (Hospitals, Ambulatory Surgical Centers, Ophthalmology Clinics, and Eye Research Institutes) - Global Opportunity Analysis and Industry Forecast, 2014-2022

Intraocular lenses (IOLs) are a type of ophthalmic implants, which are used in surgeries pertaining to eyes. IOLs are synthetic lenses implanted inside the eye that substitute the focusing power of a natural lenses, which are surgically removed. These are used to treat myopia, astigmatism, or cataracts.

The global intraocular lens market generated $3,306 million in 2015, and is projected to reach $4,973 million by 2022, registering a CAGR of 7.0% during the study period. In terms of volume, the market is expected to grow at a CAGR of 7.1%. This is attributed to rise in geriatric population, increase in prevalence of cataract, and rise in initiatives taken by government to eliminate avoidable blindness. Moreover, rise in adoption of premium lens owing to their enhanced visual performance ensures reduced rates of astigmatism, thus supplementing the growth of the market. However, unfavorable reimbursement scenario for premium lens and postoperative complications such as refractive errors are expected to restrain the market growth.

The intraocular lens market is segmented based on type, material, end user, and geography. On the basis of type, the market is bifurcated into monofocal and premium intraocular lens. The premium intraocular lens is sub-segmented into toric, multifocal, accommodating, and others (blue light filtering, phakic, and aspheric intraocular lens). By material, the market is categorized into polymethylmethacrylate (PMMA), silicone, and hydrophobic acrylic. According to end user, it is divided into hospitals, ambulatory surgical centers, ophthalmology clinics, and eye research institutes. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Prominent players adopted product development and product launches & approvals as their key developmental strategies to expand their product portfolio. For instance, in July 2016, Abott Medical Optics (now acquired by Johnson & Johnson) received FDA approval for the use of Tecnis Symfony Intraocular lenses for the treatment of cataract.

KEY BENEFITS

This report provides an extensive analysis of the current and emerging market trends and dynamics in the global intraocular lens market.
This study provides the competitive landscape of the global market to predict the competitive environment across geographies.
This report entails the detailed quantitative analysis of the current trends and future estimations to identify the prevailing opportunities.
Comprehensive analysis of factors that drive and restrict the market growth is provided in the report.
Region- and country-wise analysis is provided to understand the market trends and dynamics.

KEY MARKET SEGMENTS

By Type

Monofocal Intraocular Lens
Premium Intraocular Lens
Toric Intraocular Lens
Multifocal Intraocular Lens
Accommodating Intraocular Lens
Others
Blue Light Filtering Intraocular Lens
Phakic Intraocular Lens
Aspheric Intraocular Lens

By Material

Polymethylmethacrylate (PMMA)
Silicone
Hydrophobic Acrylic

By End User

Hospitals
Ambulatory Surgery Centers
Ophthalmology Clinics
Eye Research Institutes

By Region

North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Netherlands
Norway
Russia
Sweden
Switzerland
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
New Zealand
Taiwan
Thailand
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Chile
Columbia
Egypt
Iran
Israel
Turkey
Venezuela
Rest of LAMEA
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Carl Zeiss Meditec AG
  • EyeKon Medical, Inc.
  • HOYA GROUP
  • HumanOptics AG
  • Johnson & Johnson
  • Lenstec, Inc.
  • MORE
CHAPTER 1. INTRODUCTION

1.1. KEY BENEFITS
1.2. KEY MARKET SEGMENTS
1.3. RESEARCH METHODOLOGY

1.3.1. Secondary research
1.3.2. Primary research
1.3.3. Analyst tools and models

CHAPTER 2. EXECUTIVE SUMMARY

2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE

CHAPTER 3. MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top winning strategies
3.2.2. Top investment pockets

3.3. MARKET SHARE ANALYSIS, 2015
3.4. MARKET DYNAMICS

3.4.1. Drivers

3.4.1.1. Increasing prevalence of cataract
3.4.1.2. Rise in adoption of premium intraocular lens
3.4.1.3. Increasing government initiatives
3.4.1.4. Increasing pool of geriatric population susceptible to ocular conditions
3.4.1.5. Growing number of diabetic patients

3.4.2. Restraints

3.4.2.1. Post-operative complications
3.4.2.2. Lack of coverage of premium lens

3.4.3. Opportunity

3.4.3.1. Availability of advanced technologies
3.4.3.2. Emerging nations

3.4.4. Impact analysis

3.5. PORTERS FIVE FORCES ANALYSIS

3.5.1. Bargaining power of buyers
3.5.2. Bargaining power of suppliers
3.5.3. Threat of substitutes
3.5.4. Threat of new entrants
3.5.5. Competitive rivalry

3.6. GOVERNMENT REGULATIONS
3.7. CLINICAL TRIALS

CHAPTER 4. GLOBAL INTRAOCULAR LENS MARKET, BY TYPE

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. MONOFOCAL IOLS

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. PREMIUM IOLS

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

4.3.3.1. Toric intraocular lenses
4.3.3.2. Market size and forecast
4.3.3.3. Multifocal intraocular lenses
4.3.3.4. Market size and forecast
4.3.3.5. Accommodating intraocular lenses
4.3.3.6. Market size and forecast
4.3.3.7. Other IOLs
4.3.3.8. Market size and forecast

4.3.3.8.1. Blue light filtering IOLs
4.3.3.8.2. Market size and forecast
4.3.3.8.3. Phakic IOLs
4.3.3.8.4. Market size and forecast
4.3.3.8.5. Aspheric IOLs
4.3.3.8.6. Market size and forecast

CHAPTER 5. GLOBAL INTRAOCULAR LENSES MARKET BY END USER

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. HOSPITALS

5.2.1. Market size and forecast

5.3. AMBULATORY SURGICAL CENTERS (ASCS)

5.3.1. Market size and forecast

5.4. OPTHALMOLOGY CLINICS

5.4.1. Market size and forecast

5.5. EYE RESEARCH INSTITUTES

5.5.1. Market size and forecast

CHAPTER 6. GLOBAL INTRAOCULAR LENS MARKET, BY MATERIAL

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. POLYMETHYLMETHACRYLATE (PMMA)

6.2.1. Market size and forecast

6.3. SILICONE

6.3.1. Market size and forecast

6.4. HYDROPHOBIC ACRYLIC

6.4.1. Market size and forecast

CHAPTER 7. GLOBAL INTRAOCULAR LENS MARKET, BY REGION

7.1. OVERVIEW

7.1.1. Market size and forecast

7.2. NORTH AMERICA

7.2.1. Key market trends
7.2.2. Growth factors and opportunities
7.2.3. Market size and forecast
7.2.4. U.S. market size and forecast
7.2.5. Canada market size and forecast
7.2.6. Mexico market size and forecast

7.3. EUROPE

7.3.1. Key market trends
7.3.2. Growth factors and opportunities
7.3.3. Market size and forecast
7.3.4. Germany market size and forecast
7.3.5. France market size and forecast
7.3.6. UK market size and forecast
7.3.7. Italy market size and forecast
7.3.8. Spain market size and forecast
7.3.9. Netherlands market size and forecast
7.3.10. Norway market size and forecast
7.3.11. Russia market size and forecast
7.3.12. Sweden market size and forecast
7.3.13. Switzerland market size and forecast
7.3.14. Rest of Europe market size and forecast

7.4. ASIA-PACIFIC

7.4.1. Key market trends
7.4.2. Growth factors and opportunities
7.4.3. Market size and forecast
7.4.4. Japan market size and forecast
7.4.5. China market size and forecast
7.4.6. India market size and forecast
7.4.7. Australia market size and forecast
7.4.8. South Korea market size and forecast
7.4.9. New Zealand market size and forecast
7.4.10. Taiwan market size and forecast
7.4.11. Thailand market size and forecast
7.4.12. Rest of Asia-Pacific market size and forecast

7.5. LAMEA

7.5.1. Key market trends
7.5.2. Growth factors and opportunities
7.5.3. Market size and forecast
7.5.4. Brazil market size and forecast
7.5.5. Saudi Arabia market size and forecast
7.5.6. South Africa market size and forecast
7.5.7. Chile market size and forecast
7.5.8. Columbia market size and forecast
7.5.9. Egypt market size and forecast
7.5.10. Iran market size and forecast
7.5.11. Israel market size and forecast
7.5.12. Turkey market size and forecast
7.5.13. Venezuela market size and forecast
7.5.14. Rest of LAMEA market size and forecast

CHAPTER 8. COMPANY PROFILES

8.1. ALCON (A NOVARTIS AG DIVISION)

8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Business performance
8.1.5. Key strategic moves and developments
8.1.6. Strategy share (%)

8.2. CARL ZEISS MEDITEC AG

8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Business performance
8.2.5. Key strategic moves and developments
8.2.6. Strategy share (%)

8.3. EYEKON MEDICAL, INC.

8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Business performance
8.3.5. Key strategic moves and developments
8.3.6. Strategy share (%)

8.4. HUMANOPTICS AG

8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Business performance
8.4.5. Key strategic moves and developments
8.4.6. Strategy share (%)

8.5. HOYA GROUP

8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Business performance
8.5.5. Key strategic moves and developments
8.5.6. Strategy share (%)

8.6. JOHNSON & JOHNSON

8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Business performance
8.6.5. Key strategic moves and developments
8.6.6. Strategy share (%)

8.7. LENSTEC, INC.

8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Business performance
8.7.5. Key strategic moves and developments
8.7.6. Strategy share (%)

8.8. RAYNER

8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Business performance
8.8.5. Key strategic moves and developments
8.8.6. Strategy share (%)

8.9. STAAR SURGICAL

8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Business performance
8.9.5. Key strategic moves and developments
8.9.6. Strategy share (%)

8.10. VALEANT

8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Business performance
8.10.5. Key strategic moves and developments
8.10.6. Strategy share (%)
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Carl Zeiss Meditec AG
  • EyeKon Medical, Inc.
  • HOYA GROUP
  • HumanOptics AG
  • Johnson & Johnson
  • Lenstec, Inc.
  • MORE
Intraocular Lens Market Report, forecasts that the global market was valued at $3,306 million in 2015 and is expected to garner $4,973 million by 2022, registering a CAGR of 5.9% during the forecast period 2016 - 2022. Monofocal intraocular lens segment held more than four-fifths share of the total market in 2015.

Intraocular lens (IOLs) are implanted in the eyes to replace the natural lens during cataract surgery. The market has witnessed significant growth in the recent past due to development of new types of IOLs.

Advent of premium IOLs such as multifocal, toric, and accommodating IOLs and rise in incidence of cataract are the key factors that drive the market growth. In addition, rise in geriatric population and proactive initiatives taken by government to eliminate avoidable blindness are anticipated to fuel the demand for IOLs globally. However, postoperative complications such as refractive errors and unfavorable reimbursement scenario for premium intraocular lens restrict the market growth.

The monofocal intraocular lens segment is expected to dominate the market during the analysis period, owing to its advantages such as low and better reimbursement scenario

Silicone generated the maximum revenue, accounting for more than half of the global intraocular lens market in 2015. However, hydrophobic acrylic segment is estimated to exhibit the highest growth rate of 7.1% during the forecast period.

Ambulatory surgery centers generated the highest revenue, accounting for nearly half of the global market, and is estimated to grow at the highest CAGR of 6.7%.

Key Findings of Intraocular Lens Market

Premium lens segment is expected to grow at a significant CAGR of 8.6%, owing to various benefits such as improved visual performance.
Ambulatory surgery center segment is projected to grow at a CAGR of 7.1% during the forecast period.
In terms of volume, the U.S. accounted for more than one-fourth share of the global intraocular lens market.
France and Germany collectively contributed for more than one-third of the European intraocular lens market in 2015.
Japan is the major shareholder, accounting for almost one-third of the Asia-Pacific intraocular lens market in 2015.
Asia-Pacific is projected to grow at the highest CAGR of 7.0% during the forecast period owing to improvement in healthcare infrastructures and rise in expenditures in emerging markets (such as India and China) to cater to the unmet medical needs. Technological advancements to develop cost-effective devices offer lucrative opportunities for the market growth.

The major companies profiled in the report include are Alcon, Inc. (division of Novartis AG), Johnson & Johnson, Valeant, Carl Zeiss Meditec AG, Rayner, EyeKon Medical, Inc., Lenstec, Inc., HumanOptics AG, STAAR Surgical, and HOYA GROUP. The other players operating in the market include PhysIOL s.a., Calhoun Vision Center, and Oculentis GmBH.
Note: Product cover images may vary from those shown
5 of 5
  • Alcon, Inc. (division of Novartis AG)
  • Carl Zeiss Meditec AG
  • EyeKon Medical, Inc.
  • HOYA GROUP
  • HumanOptics AG
  • Johnson & Johnson
  • Lenstec, Inc.
  • Rayner
  • STAAR Surgical
  • Valeant
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll